B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
about
CNS immune privilege: hiding in plain sight.Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transportIncreased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats.Hypersensitivity Responses in the Central Nervous SystemModels of autoimmune demyelination in the central nervous system: on the way to translational medicine.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis.Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiologyB-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator.Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity.T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.Knockout mice: a paradigm shift in modern immunology.Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.Characterization of antigen-specific B cells using nominal antigen-coated flow-beads.Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenesAutoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors.Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies.A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells.Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune DiseaseB cell repertoire expansion occurs in meningeal ectopic lymphoid tissue.IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitisInvestigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived ImmunoglobulinsB cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity.Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodiesAutoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.Building different mouse models for human MS.Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
P2860
Q24642697-F29E183F-F62A-4D9F-B480-A310FD4C527BQ24683357-C662BEC5-7CB7-48AC-BE56-AA8EEEF1EDCAQ24801675-71B3683F-8396-4B2E-B576-8EC649D889C6Q26779177-E56769C8-B89A-41B8-9AF5-4AF801174CB1Q30483471-222740E0-E963-49A9-975A-4E05CE282201Q33645795-1DBD31D3-050F-4570-A335-609CD7701A7CQ33713298-BF1F1BA8-43AC-464B-87FF-DCDAC5E34AEEQ33841113-7F7B4D59-F1BF-4D1B-A0B5-4B7452684604Q34048094-D10FD999-9C4E-49F1-8C74-9F2687B627F5Q34079588-62B58C85-FB42-44E2-9EA2-8E9DA90CA8F1Q34345420-90894EF1-6ABD-4362-990D-DA432558F6C3Q34352839-7959C7EA-537B-4111-925D-B459A5A80CF3Q34398673-FF6BF992-0BBB-4741-901E-E6497E6B3F93Q34572115-8A235260-3E31-4AB1-B279-578EF8A39F3FQ35009513-3B9EDEE6-88EE-4C48-BD5E-A83BFDA5BCF0Q35009518-2AA97D26-A763-4663-9CDA-D368BE187CAAQ35080887-450B5B4A-D987-4FD8-B07A-086275EA496CQ35160175-64D59A67-E5D0-4C22-A99E-EF7AE9131310Q35214738-750C5FCC-ED7C-41C1-BE7D-30FF2F759889Q35242814-C9C0253F-05CA-456E-92ED-6EFEA792081CQ35594364-B04843E9-C948-4902-88DC-0EDE3B92C438Q35613006-3A982412-CA21-4947-8715-32B781F7E79CQ35674246-FD5D8530-6694-4F10-B338-B5561065C789Q35750102-5017DD19-F8C8-4490-BE4F-201DE2E11F33Q35753383-8F7BE756-3C56-4F1A-BCE7-DB7F78C690F2Q35785943-A0408C31-5CCE-4475-9944-F7C90BB46DF2Q35949316-EB4D4B08-9F2C-4861-9493-712D5E40B6C2Q35967534-AFA67BE3-F1B4-4A60-8129-0676663D1F9FQ36097332-CB6149F0-B583-45FD-8A3A-ACFADD69542FQ36220292-5274F759-D7AA-4297-B965-5D487E8AA2AAQ36281698-8ECEBA4C-5DE6-4302-8E59-AFFD458AF1ECQ36330016-C1577ACB-5BD6-40E9-87BB-B335BC3F48D7Q36371044-6EE8B0CC-BFDE-410D-980F-92BF2E63BEDEQ36634895-75F92E35-098D-4027-B711-D9922A190E61Q36689886-FB93A43D-DA3C-46C2-8729-796544B4048EQ36742838-D76A3FF9-4F5A-4655-A6D8-6B5F4A47AFACQ36761844-B0023B8A-8F25-4F79-8776-07B20DF98A33Q36766153-67EB4930-D5DA-431D-B97A-9521787FD9E4Q36803471-B33C8ABD-0FED-42D2-A5F2-FF681FF88294Q36866185-C19DA55F-76DD-44AB-B1C1-4874CEDC19E6
P2860
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
B lymphocytes producing demyel ...... gene-targeted transgenic mice.
@en
type
label
B lymphocytes producing demyel ...... gene-targeted transgenic mice.
@en
prefLabel
B lymphocytes producing demyel ...... gene-targeted transgenic mice.
@en
P2093
P2860
P356
P1476
B lymphocytes producing demyel ...... gene-targeted transgenic mice.
@en
P2093
A Iglesias
C Linington
T Litzenburger
P2860
P304
P356
10.1084/JEM.188.1.169
P407
P577
1998-07-01T00:00:00Z